Literature DB >> 34364035

Human inborn errors of immunity to oncogenic viruses.

Vivien Béziat1, Emmanuelle Jouanguy2.   

Abstract

Oncoviruses are viruses that can cause tumors. Seven viruses are currently recognized as oncogenic in humans: Epstein Barr virus (EBV), Kaposi sarcoma-associated herpesvirus (KSHV, also known as HHV8), human papillomaviruses (HPVs), hepatitis B virus (HBV), hepatitis C virus (HCV), human T-lymphotropic virus-1 (HTLV-1), and Merkel cell polyomavirus (MCPyV). The clinical phenotypes resulting from infection with these oncoviruses range from asymptomatic infection to invasive cancers. Patients with inborn errors of immunity (IEI) are prone to the development of infectious diseases caused by a narrow or broad spectrum of pathogens, including oncoviruses in some cases. Studies of patients with IEI have deepened our understanding of the non-redundant mechanisms underlying the control of EBV, HHV8 and HPV infections. The human genetic factors conferring predisposition to oncogenic HBV, HCV, HTLV-1 and MCPyV manifestations remain elusive. We briefly review here what is currently known about the IEI conferring predisposition to severe infection with oncoviruses.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34364035      PMCID: PMC8721657          DOI: 10.1016/j.coi.2021.06.017

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.268


  86 in total

1.  X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease.

Authors:  Claire Booth; Kimberly C Gilmour; Paul Veys; Andrew R Gennery; Mary A Slatter; Helen Chapel; Paul T Heath; Colin G Steward; Owen Smith; Anna O'Meara; Hilary Kerrigan; Nizar Mahlaoui; Marina Cavazzana-Calvo; Alain Fischer; Despina Moshous; Stephane Blanche; Jana Pachlopnik Schmid; Jana Pachlopnick-Schmid; Sylvain Latour; Genevieve de Saint-Basile; Michael Albert; Gundula Notheis; Nikolaus Rieber; Brigitte Strahm; Henrike Ritterbusch; Arjan Lankester; Nico G Hartwig; Isabelle Meyts; Alessandro Plebani; Annarosa Soresina; Andrea Finocchi; Claudio Pignata; Emilia Cirillo; Sonia Bonanomi; Christina Peters; Krzysztof Kalwak; Srdjan Pasic; Petr Sedlacek; Janez Jazbec; Hirokazu Kanegane; Kim E Nichols; I Celine Hanson; Neena Kapoor; Elie Haddad; Morton Cowan; Sharon Choo; Joanne Smart; Peter D Arkwright; Hubert B Gaspar
Journal:  Blood       Date:  2010-10-06       Impact factor: 22.113

2.  DOCK8 deficiency: clinical and immunological phenotype and treatment options - a review of 136 patients.

Authors:  Susanne E Aydin; Sara Sebnem Kilic; Caner Aytekin; Ashish Kumar; Oscar Porras; Leena Kainulainen; Larysa Kostyuchenko; Ferah Genel; Necil Kütükcüler; Neslihan Karaca; Luis Gonzalez-Granado; Jordan Abbott; Daifulah Al-Zahrani; Nima Rezaei; Zeina Baz; Jens Thiel; Stephan Ehl; László Marodi; Jordan S Orange; Julie Sawalle-Belohradsky; Sevgi Keles; Steven M Holland; Özden Sanal; Deniz C Ayvaz; Ilhan Tezcan; Hamoud Al-Mousa; Zobaida Alsum; Abbas Hawwari; Ayse Metin; Susanne Matthes-Martin; Manfred Hönig; Ansgar Schulz; Capucine Picard; Vincent Barlogis; Andrew Gennery; Marianne Ifversen; Joris van Montfrans; Taco Kuijpers; Robbert Bredius; Gregor Dückers; Waleed Al-Herz; Sung-Yun Pai; Raif Geha; Gundula Notheis; Carl-Philipp Schwarze; Betül Tavil; Fatih Azik; Kirsten Bienemann; Bodo Grimbacher; Valerie Heinz; H Bobby Gaspar; Roland Aydin; Beate Hagl; Benjamin Gathmann; Bernd H Belohradsky; Hans D Ochs; Talal Chatila; Ellen D Renner; Helen Su; Alexandra F Freeman; Karin Engelhardt; Michael H Albert
Journal:  J Clin Immunol       Date:  2015-01-28       Impact factor: 8.317

3.  HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy.

Authors:  K J Jeffery; K Usuku; S E Hall; W Matsumoto; G P Taylor; J Procter; M Bunce; G S Ogg; K I Welsh; J N Weber; A L Lloyd; M A Nowak; M Nagai; D Kodama; S Izumo; M Osame; C R Bangham
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

Review 4.  Considerations in surgical management of a Buschke-Lowenstein tumor in Netherton syndrome: A case report.

Authors:  Rosalind Ashton; Jamil Moledina; Branavan Sivakumar; Jemima E Mellerio; Anna E Martinez
Journal:  Pediatr Dermatol       Date:  2017-11       Impact factor: 1.588

5.  CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia.

Authors:  Joris M van Montfrans; Andy I M Hoepelman; Sigrid Otto; Marielle van Gijn; Lisette van de Corput; Roel A de Weger; Linda Monaco-Shawver; Pinaki P Banerjee; Elisabeth A M Sanders; Cornelia M Jol-van der Zijde; Michael R Betts; Jordan S Orange; Andries C Bloem; Kiki Tesselaar
Journal:  J Allergy Clin Immunol       Date:  2011-12-24       Impact factor: 10.793

6.  Immunodeficiency and EBV-induced lymphoproliferation caused by 4-1BB deficiency.

Authors:  Mohammed F Alosaimi; Manfred Hoenig; Faris Jaber; Craig D Platt; Jennifer Jones; Jacqueline Wallace; Klaus-Michael Debatin; Ansgar Schulz; Eva Jacobsen; Peter Möller; Hanan E Shamseldin; Ferdous Abdulwahab; Niema Ibrahim; Hosam Alardati; Faisal Almuhizi; Ibraheem F Abosoudah; Talal A Basha; Janet Chou; Fowzan S Alkuraya; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2019-03-11       Impact factor: 10.793

Review 7.  Human Genetic Determinants of Viral Diseases.

Authors:  Adam D Kenney; James A Dowdle; Leonia Bozzacco; Temet M McMichael; Corine St Gelais; Amanda R Panfil; Yan Sun; Larry S Schlesinger; Matthew Z Anderson; Patrick L Green; Carolina B López; Brad R Rosenberg; Li Wu; Jacob S Yount
Journal:  Annu Rev Genet       Date:  2017-08-30       Impact factor: 16.830

8.  Merkel cell carcinoma in a patient with GATA2 deficiency: a novel association with primary immunodeficiency.

Authors:  C Crall; K W Morley; G Rabinowits; B Schmidt; A Dioun Broyles; J T Huang
Journal:  Br J Dermatol       Date:  2015-11-03       Impact factor: 9.302

Review 9.  Primary immunodeficiencies reveal the molecular requirements for effective host defense against EBV infection.

Authors:  Stuart G Tangye; Sylvain Latour
Journal:  Blood       Date:  2020-02-27       Impact factor: 22.113

10.  Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.

Authors:  David L Thomas; Chloe L Thio; Maureen P Martin; Ying Qi; Dongliang Ge; Colm O'Huigin; Judith Kidd; Kenneth Kidd; Salim I Khakoo; Graeme Alexander; James J Goedert; Gregory D Kirk; Sharyne M Donfield; Hugo R Rosen; Leslie H Tobler; Michael P Busch; John G McHutchison; David B Goldstein; Mary Carrington
Journal:  Nature       Date:  2009-10-08       Impact factor: 49.962

View more
  3 in total

1.  Hyper-IgE and Carcinoma in CADINS Disease.

Authors:  Leonora Pietzsch; Julia Körholz; Felix Boschann; Mildred Sergon; Batsukh Dorjbal; Debra Yee; Vanessa Gilly; Eva Kämmerer; Diana Paul; Clemens Kastl; Martin W Laass; Reinhard Berner; Eva Maria Jacobsen; Joachim Roesler; Daniela Aust; Min A Lee-Kirsch; Andrew L Snow; Catharina Schuetz
Journal:  Front Immunol       Date:  2022-05-16       Impact factor: 8.786

Review 2.  The Chemokine System in Oncogenic Pathways Driven by Viruses: Perspectives for Cancer Immunotherapy.

Authors:  Géraldine Schlecht-Louf; Claire Deback; Françoise Bachelerie
Journal:  Cancers (Basel)       Date:  2022-02-08       Impact factor: 6.639

Review 3.  HPV-Related Skin Phenotypes in Patients with Inborn Errors of Immunity.

Authors:  Assiya El Kettani; Fatima Ailal; Jalila El Bakkouri; Khalid Zerouali; Vivien Béziat; Emmanuelle Jouanguy; Jean-Laurent Casanova; Ahmed Aziz Bousfiha
Journal:  Pathogens       Date:  2022-07-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.